Q3 2026 13F filing
Updated 6 days ago63 disclosed positions worth $3.9B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | A Abivax SA | $392.1M | 3.96M | 10.13% | — |
| 2 | N Neurocrine Biosciences Inc | $354.6M | 2.50M | 9.16% | — |
| 3 | B BioMarin Pharmaceutical Inc | $331.5M | 5.53M | 8.56% | — |
| 4 | A Arrowhead Pharmaceuticals Inc | $315.1M | 4.82M | 8.14% | — |
| 5 | I Insmed Inc | $311M | 2.73M | 8.04% | — |
| 6 | U United Therapeutics Corp | $257.4M | 475.0K | 6.65% | — |
| 7 | A Ascendis Pharma A/S | $168.6M | 740.0K | 4.36% | — |
| 8 | N Nurix Therapeutics Inc | $166.6M | 7.03M | 4.30% | — |
| 9 | T Tarsus Pharmaceuticals Inc | $159.9M | 2.03M | 4.13% | — |
| 10 | E Enliven Therapeutics Inc | $147.8M | 3.23M | 3.82% | — |
| 11 | I Disc Medicine Inc | $107M | 1.64M | 2.77% | — |
| 12 | B Bicara Therapeutics Inc | $102.8M | 5.53M | 2.66% | — |
| 13 | D Dyne Therapeutics Inc | $99.9M | 6.20M | 2.58% | — |
| 14 | I Immatics NV | $98.3M | 11.20M | 2.54% | — |
| 15 | T Taysha Gene Therapies Inc | $87.9M | 18.05M | 2.27% | — |
| 16 | M Monte Rosa Therapeutics Inc | $85.1M | 7.13M | 2.20% | — |
| 17 | G Globus Medical Inc | $68.5M | 915.0K | 1.77% | — |
| 18 | C Crescent Biopharma Inc | $43.8M | 3.00M | 1.13% | — |
| 19 | Z Zimmer Biomet Holdings Inc | $42.2M | 475.0K | 1.09% | — |
| 20 | T Travere Therapeutics Inc | $35.3M | 600.0K | 0.91% | — |
| 21 | R Arcus Biosciences Inc | $33.6M | 1.30M | 0.87% | — |
| 22 | X Xenon Pharmaceuticals Inc | $31.6M | 850.0K | 0.82% | — |
| 23 | N Nektar Therapeutics | $30.9M | 510.0K | 0.80% | — |
| 24 | D Bright Minds Biosciences Inc | $27.2M | 545.0K | 0.70% | — |
| 25 | B Bridgebio Pharma Inc | $26.3M | 400.0K | 0.68% | — |
| 26 | I Immunocore Holdings PLC | $25.7M | 850.0K | 0.67% | — |
| 27 | P Insulet Corp | $22.8M | 175.0K | 0.59% | — |
| 28 | T Trevi Therapeutics Inc | $21.4M | 1.50M | 0.55% | — |
| 29 | S Sanofi SA | $20.6M | 500.0K | 0.53% | — |
| 30 | S Savara Inc | $17M | 3.30M | 0.44% | — |
| 31 | S SpyGlass Pharma Inc | $16.6M | 640.0K | 0.43% | — |
| 32 | Z Zymeworks Inc | $15.9M | 600.0K | 0.41% | — |
| 33 | C Cogent Biosciences Inc | $15.2M | 475.0K | 0.39% | — |
| 34 | S Solid Biosciences Inc | $15.1M | 2.08M | 0.39% | — |
| 35 | ? N/A Lexeo Therapeutics Inc | $14.6M | 4.32M | 0.38% | — |
| 36 | A Avalo Therapeutics Inc | $12.3M | 800.0K | 0.32% | — |
| 37 | Z Zenas Biopharma Inc | $10.7M | 395.0K | 0.28% | — |
| 38 | E Evommune Inc | $10.3M | 1.25M | 0.27% | — |
| 39 | V Viking Therapeutics Inc | $9.5M | 290.0K | 0.24% | — |
| 40 | S Stoke Therapeutics Inc | $9M | 345.0K | 0.23% | — |
| 41 | K Korsana Biosciences Inc | $8.4M | 263.1K | 0.22% | — |
| 42 | ? N/A Damora Therapeutics Inc | $8.4M | 395.0K | 0.22% | — |
| 43 | T Tectonic Therapeutic Inc | $8.4M | 360.0K | 0.22% | — |
| 44 | Z Zura Bio Ltd | $7.7M | 1.86M | 0.20% | — |
| 45 | G Glaukos Corp | $7.4M | 45.0K | 0.19% | — |
| 46 | K Kailera Therapeutics Inc | $7.1M | 625.0K | 0.18% | — |
| 47 | A Anteris Technologies Global Co | $6.6M | 850.0K | 0.17% | — |
| 48 | M MoonLake Immunotherapeutics | $6.1M | 525.0K | 0.16% | — |
| 49 | R Rezolute Inc | $6M | 1.46M | 0.16% | — |
| 50 | T First Tracks Biotherapeutics I | $6M | 169.7K | 0.16% | — |